IP Library Granted Patent US 9,549,893
Granted Patent B2
US 9,549,893 · App. 14/542,041 · Granted Jan 24, 2017

Compositions and kits for the removal of irritating compounds from bodily surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,549,893
App. No.
14/542,041
Granted
Jan 24, 2017
Kind
B2
Abstract

The invention provides compositions, methods and kits for the removal of harmful or irritating substances from bodily surfaces. Kits may include a composition containing capsaicin and a capsaicin-cleansing composition, e.g., a composition in which capsaicin is soluble.

Claims (26)

1. A method for treating pain in an individual, comprising:

a) applying to an area of the body affected by pain a first composition comprising capsaicin or a capsaicin analog in a total concentration from greater than 5% to 10% by weight of the first composition, wherein the first composition is a lotion or an emulsion; and

b) cleansing the area to which the first composition has been applied by

i) applying to the area a second, surfactant-free gel composition comprising 80 to 99 percent w/w polyethylene glycol; and

ii) wiping the second, surfactant-free gel composition from the area after the second, surfactant-free composition has been on the area for a time period sufficient to solubilize at least 10% w/w of the capsaicin or the capsaicin analog.

2. The method of claim 1 , wherein the first composition comprises capsaicin.

3. The method of claim 1 , wherein the first composition comprises a capsaicin analog.

4. The method of claim 1 , wherein the time period is one minute.

5. The method of claim 1 , wherein the pain being treated is neuropathic pain.

6. The method of claim 5 , wherein the neuropathic pain is selected from the group consisting of diabetic neuropathy, postherpetic neuralgia, HIV/AIDS, traumatic injury, complex regional pain syndrome, trigeminal neuralgia, ethrythromyalgia, and phantom pain.

7. The method of claim 1 , wherein the second, surfactant-free composition comprises:

a) 87 to 91 percent w/w of the polyethylene glycol;

b) 0.3 to 1.5 percent w/w polyacrylate thickening agent;

c) 0.01 to 0.03 percent w/w butylated hydroxyanisole;

d) 0.02 to 0.2 percent w/w disodium edetate;

e) 0.03 to 0.04 percent w/w sodium hydroxide; and

f) 9.0 to 10.0 percent w/w water.

8. The method of claim 1 , wherein the second, surfactant-free composition comprises:

a) 89.08 percent w/w of the polyethylene glycol;

b) 1.00 percent w/w polyacrylate thickening agent;

c) 0.02 percent w/w butylated hydroxyanisole;

d) 0.10 percent w/w disodium edetate;

e) 0.30 percent w/w sodium hydroxide; and

f) 9.50 percent w/w water.

9. The method of claim 1 , wherein the second, surfactant-free composition further comprises a cooling agent.

10. The method of claim 1 , further comprising administering an afferent nerve fiber blocking regional anesthetic the area of the body affected by pain.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2019
From: GRÜNENTHAL GMBH
To: AVERITAS PHARMA INC.
Reel/Frame 050065/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2019
From: ACORDA THERAPEUTICS, INC.
To: GRÜNENTHAL GMBH
Reel/Frame 049260/0707 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2016
From: NEUROGESX, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 040508/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2016
From: ANGEL, ARTURO J.; LITLE, LARRY W.
To: DOW PHARMACEUTICAL SCIENCES
Reel/Frame 040190/0896 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2016
From: DOW PHARMACEUTICAL SCIENCES
To: NEUROGESX, INC.
Reel/Frame 040190/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2016
From: BLEY, KEITH R.; WILCOX, ALLAN L.; JAMIESON, GENE C.; MUHAMMAD, NAWEED
To: NEUROGESX, INC.
Reel/Frame 040190/0885 →
SECURITY INTEREST Recorded Jun 10, 2016
From: ACORDA THERAPEUTICS, INC.; CIVITAS THERAPEUTICS, INC.; NEURONEX, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038950/0436 →